Looking for biomarkers in metronomic chemotherapy

New metronomic approach to neuroblastoma

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

Quality of life and cost advantages of metronomics and drug repurposing

Advances in multiple myeloma: Expert panel discussion

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

Networking and collaborating across borders in sub-Saharan Africa

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care

Systems medicine approach to optimise drugs and drug combinations for individual AML patients

Work of the WIN consortium and challenges of personalised cancer therapy

Molecular investigations of immune cells and tumour environment: The ovarian cancer model

Cancer stem cells and malignant progression